![Obtryx II System](/medias/700Wx700H-M0068504110-1.jpg?context=bWFzdGVyfHJvb3R8NDU1Nzd8aW1hZ2UvanBlZ3xhRFJpTDJoaE15ODRPRE01TVRjM01qUXdOakEyTHpjd01GZDROekF3U0Y5Tk1EQTJPRFV3TkRFeE1GOHhMbXB3Wnd8ZmIwNzg5NDUzZjVjZmNmMGY3MTYwMWM0ZGJhMGYwODk5MWJjYTMwNTUyY2E3NzU4ZWEyNTE3ZTcyYjFkM2MwOA)
![Obtryx II System](/medias/700Wx700H-M0068504110-2.jpg?context=bWFzdGVyfHJvb3R8MjI2ODZ8aW1hZ2UvanBlZ3xhRGszTDJneFlpODRPRE01TVRjMU9EWTBNelV3THpjd01GZDROekF3U0Y5Tk1EQTJPRFV3TkRFeE1GOHlMbXB3Wnd8OGUwMTdhNTE5NGEwN2M1ODU4ZjE2ZTlmYTgzOGEyZGE4OGE1Zjc2NWI0ZWNmZDk5YWEyMjY0ZmQ4YTljNDQ2Nw)
![Obtryx II System](/medias/700Wx700H-M0068504110-3.jpg?context=bWFzdGVyfHJvb3R8MzQ0MjR8aW1hZ2UvanBlZ3xhRFE1TDJoaE5pODRPRE01TVRjM016QTJNVFF5THpjd01GZDROekF3U0Y5Tk1EQTJPRFV3TkRFeE1GOHpMbXB3Wnd8ZTNkZGJiNTIxMjNhNmM3YzFkMjkxMzllNmJmZGU3YzQzOWQzYjE4NzQwMTRlMGQ1MmExYWNlYmUxZWEwMWFkYw)
Obtryx™ IIObtryx II Transobturator Sling System - Curved
The mesh implant is intended as a suburethral sling for the treatment of stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency. The delivery devices are intended for use as an aid in insertion, placement, fixation, and anchoring of surgical mesh during urogynecological procedures.
Select Product:
Product Details
Transobturator sling with enhanced features that are designed to provide smooth sling placement, intra-operative adjustability designed for minimal tissue disruption, and increased physician visualization that aids in precise sling placement.
Needle Design
- Needle tip length is designed to facilitate transobturator device passage
- Two needle configurations, halo and curved, allow physicians to choose the needle that meets their preference
- Association Loop
- Designed to facilitate needle engagement and removal
Dilator Legs
- Designed to create a small delivery track due to thin leg size and provide smooth delivery of the sling through the anatomy
- Designed for minimal tissue disruption
Sub-Urethral Segment
- No sleeve coverage under the sub-urethral segment to allow for visibility and to aid in precise placement
Centering Tab
- Blue centering tab identifies the center of the mesh and provides for equal distribution of mesh on each side of the urethra
Caution: For Female Mid-Urethral Slings: Federal (US) law restricts this device to sale by or on the order of a physician trained in use of surgical mesh for repair of stress urinary incontinence.
Refer to package insert provided with this product for complete Indications for Use, Contraindications, Warnings, Precautions, Adverse Events, and Instructions prior to using this product.
Potential risks for Boston Scientific Suburetheral slings: The following adverse events have been reported due to suburethral sling placement, any of which may be ongoing, but are not limited to: As with all implants, local irritation at the wound site and/or a foreign body response may occur, Foreign body reaction may be acute or chronic, Pain (pelvic, vaginal, groin/thigh, suprapubic, dyspareunia) (acute or chronic), Dyspareunia, Tissue responses to the mesh implant could include: erosion into organs (urethra, bladder or other surrounding tissues); exposure/extrusion into the vagina, Mesh contact with urine via erosion/exposure/extrusion may result in stone formation, scarring/scar contracture, Necrosis, fistula formation (acute or chronic), inflammation (acute or chronic), Mesh contracture, Tissue contracture, Vaginal shortening or stenosis that may result in dyspareunia and/or sexual dysfunction, Pain with intercourse that may not resolve, Exposed mesh may cause pain or discomfort to the patient’s partner during intercourse, Sexual dysfunction, including the inability to have intercourse. Like all foreign bodies, the mesh may potentiate an existing infection. Allergic reaction has been reported. Known risks of surgical procedures for the treatment of incontinence include: pain, ongoing pain (pelvic, vaginal, groin/thigh, suprapubic, dyspareunia), Severe, chronic pain, Apareunia, Leg weakness, Infection, De novo detrusor instability, Complete failure of the procedure/failure to resolve a patient’s stress urinary incontinence, Voiding dysfunction (incontinence, temporary or permanent lower urinary tract obstruction, difficulty urinating, pain with urination, overactive bladder, and retention), Bruising, bleeding (vaginal, hematoma formation), Abscess, Vaginal discharge, Dehiscence of vaginal incision, Edema and erythema at the wound site, Perforation or laceration of vessels, nerves, bladder, urethra or bowel may occur during placement. The following additional adverse events have been reported for the Solyx SIS System: Dysuria, Hematuria. The occurrence of these events may require surgical intervention and possible removal of the entire mesh. In some instances, these events may persist as a permanent condition after surgical intervention or other treatment. Removal of mesh or correction of mesh-related complications may involve multiple surgeries. Complete removal of mesh may not be possible and additional surgeries may not always fully correct the complications.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All images are the property of Boston Scientific.
All trademarks are the property of their respective owners.